微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 60.05% | -0.98% | -1.56% | 60/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 61.01% | -0.53% | 3.23% | 55/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 59.1% | 0.24% | -1.21% | 57/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 59.82% | 1.13% | -1.36% | 57/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 60.65% | 0.93% | -1.11% | 57/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 61.33% | 1.17% | 4.03% | 51/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 58.95% | 1.5% | -0.34% | 59/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 59.15% | -0.79% | -1.55% | 57/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 60.09% | 0.75% | -0.88% | 58/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 60.62% | 0.26% | 4.37% | 52/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 58.08% | -2.02% | -2.59% | 58/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 59.63% | -1.73% | -0.02% | 57/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 59.64% | 0.23% | -1.36% | 56/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 60.46% | 6.54% | 1.98% | 54/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 59.28% | 5.32% | -2.29% | 57/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 60.67% | 2.76% | 1.97% | 52/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 59.5% | 0.7% | 4.86% | 61/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 56.75% | -5.39% | 0.81% | 66/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 56.29% | -3.9% | -4.66% | 75/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 59.04% | -4.65% | -0.08% | 61/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 59.09% | -4.01% | -1.48% | 65/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 59.98% | -3.62% | 2.39% | 57/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 58.58% | -3.84% | -5.4% | 73/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 61.92% | 1.25% | 0.6% | 49/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 61.56% | 1.71% | -1.09% | 55/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 62.23% | 2% | 2.16% | 37/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 60.92% | -0.38% | -0.4% | 58/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 61.16% | 2% | 1.05% | 30/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 60.52% | 2% | -1.02% | 37/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 61.15% | 2.91% | 2.91% | 52/141 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2017-12-31 | 59.42% | 3.35% | 3.35% | 52/141 | 56.1% | 正海生物 | 93.08% | 行业排名> |
| 2016-12-31 | 57.49% | 2% | 2% | 39/141 | 57.35% | 正海生物 | 92.83% | 行业排名> |